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Summary. The generalized Lotka-Volterra (gLV) equations model the micro-
biome as a collection of interacting ecological species. Here we use a particular
experimentally-derived gLV model of C. difficile infection (CDI) as a case study to
generate methods that are applicable to generic gLV models. We examine how to
transition gLV systems between multiple steady states through the application of
direct control protocols, which alter the state of the system via the instantaneous
addition or subtraction of microbial species. Then, the geometry of the basins of
attraction of point attractors is compressed into an attractor network, which decom-
poses a multistable high-dimensional landscape into web of bistable subsystems.
This attractor network is used to identify efficient (total intervention volume mini-
mizing) protocols that drive the system from one basin to another. In some cases, the
most efficient control protocol is circuitous and will take the system through inter-
mediate steady states with sequential interventions. Clinically, the efficient control
of the microbiome has pertinent applications for bacteriotherapies, which seek to
remedy microbiome-affiliated diseases by directly altering the composition of the
gut microbiome.
1.1 Introduction
In this chapter we characterize the dynamics of the generalized Lotka-Volterra (gLV)
equations, a set of nonlinear coupled differential equations that are traditionally used
in theoretical ecology to study interacting populations. In particular, gLV models
are examined in the context of the gut microbiome, which consists of an ensemble
of microorganisms that inhabit the gastrointestinal tract. Our scope is restricted to
ecological dynamics that relax towards attractors; in this case microbial dynamics
follow a pseudo-energy landscape similar to a Lyapunov function, in which minima
of the landscape correspond to steady states of the system.
Canonically, landscape-based descriptions of biological processes have been used
to describe how cell fates are determined in Waddington’s epigenetic landscape, and
more recently they have been employed to study the genetic landscape of gene regula-
tory networks [1]. In this gene regulatory network study, high-dimensional dynamics
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are characterized using an attractor network, which compresses the geometric struc-
ture of the basins of attraction of fixed points into a graph. In this chapter we apply
attractor networks to describe a multi-stable gLV system by a web of interconnected
bistable landscapes. By mapping the structure of dynamical landscapes, attractor
networks inform the control of steady-state outcomes in gLV systems.
The study of the microbiome is motivated by a desire to better understand the
ecological dynamics that underlie microbiome behavior, which might advance the
ability of clinicians to respond to microbiome-associated disorders and to improve
microbiome health. Experimental evidence linking microbiome to host health is re-
viewed in Section 1.4.1, and alternative mathematical models of the microbiome are
summarized in Section 1.4.2.
As a case study, we consider an experimentally-derived gLV model of Clostrid-
iodes difficile infection (CDI), and use attractor networks to inform how to navigate
between stable microbial communities of the system. The system is manipulated
with direct interventions that modify an existing microbial state by either intro-
ducing a foreign microbial population (referred to as a transplant) or by removing
existing microbial species. These direct interventions are interpreted as numerical
implementations of bacteriotherapies, and when they are successful these interven-
tions drive a microbial state into the basin of attraction of a target state. Broadly,
these results examine the ecological mechanisms that underlie the successful admin-
istration of bacteriotherapies, and inform how the intrinsic ecological dynamics of
the microbiome might be harnessed to improve the efficacy of bacteriotherapies.
1.2 Background
1.2.1 Generalized Lotka-Volterra (gLV) models
In this chapter the generalized Lotka-Volterra (gLV) equations are treated as a
mathematical proxy for the microbial dynamics of the gut microbiome. The gLV
equations describe the dynamics of a microbial population yi in a system of N total
interacting populations as
dyi
dt
= yi
(
ρi +
N∑
j=1
Kijyj
)
, i ∈ 1, . . . , N, (1.1)
where the growth rate of species i is given by ρi, and the pairwise interaction Kij
encodes the ecological effects of species j on species i.
A gLV system with N populations can exhibit up to 2N steady states, where
each steady state is specific to a distinct presence/absence combination of the N
species. Motivated by clinical bacteriotherapies like fecal microbiota transplantation
(FMT) that seek to drive a diseased microbiome towards a healthy composition,
we consider how to control the steady-state outcomes of gLV systems with direct
interventions that instantaneously supplement or deplete the microbial state of a
system. Towards this end, as in previous work [2, 4] the gLV model is extended to
include the instantaneous addition of a foreign microbial transplant v at time t∗, as
well as the administration of an antibiotic treatment u(t), so that
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Fig. 1.1. Pairwise interactions between bacterial populations interpreted
as a microbial food web. An arrow from population j to population i represents
the effect of j on the growth of i, as described by the interaction term Kij in a
generalized Lotka-Volterra model Eq (1.1). The width and opacity of an arrow are
proportional to |Kij |, and positive interactions (Kij > 0) are green while inhibitory
interactions (Kij < 0) are red. The pairwise interactions Kij here were fit from
an experimental mouse model of C. difficile infection (CDI) [2, 3]. C. difficile, the
culprit behind CDI, is colored red and located in the center of the food web. This
figure and caption are adapted from [4].
dyi
dt
= yi
(
ρi +
N∑
j=1
Kijyj
)
+ viδ(t− t∗) + u(t)εiyi, (1.2)
where vi is the ith component of the foreign transplant v, δ(·) is the Dirac delta
function, and εi is the antibiotic susceptibility of population i.
Three types of bacteriotherapy-inspired direct interventions are examined, cor-
responding to three types of transplant v: the addition of a single species (interpreted
as a probiotic), the addition of a stable external microbial community (interpreted
as fecal microbial transplant), and the removal of a particular species (interpreted as
a phage therapy). More explicitly, we consider the direct control problem in which
an initial condition is in the basin of attraction of some attractor ya, and the goal
is to identify the smallest intervention v that is able to drive the system into the
basin of attraction of some other target state yb.
We choose the cost function ϕ to be the size of the transplant,
ϕ = ‖v‖1, (1.3)
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so that the optimal control protocol minimizes the required transplant size. Since the
transplant inputs are instantaneous (i.e. Dirac-delta type), this is a sampled-data
control problem [5].
1.2.2 Experimentally-derived gLV model of C. difficile infection
We use a gLV model of C. difficile infection (CDI) as a case study for how to transi-
tion between basins of attraction. In this model, the growth rates ρ and interaction
parameters K were fit by Stein et al. to microbial abundance time-series data from a
mouse experiment performed by Buffie et al. [2, 3]. To reduce the number of param-
eters of the model, Stein et al. assumed that bacteria within a given genus behave
similarly, and consolidated the species-level data into genus-level data. In Fig. 1.1 the
interaction parameters are displayed as a food web where the circles are microbial
populations, and the edges describe the effect of one population on another, where
positive interactions (Kij > 0) are black and inhibitory interactions (Kji < 0) are
red. The interactions between populations have no clear hierarchy, indicating that
the fitted model describes microbes on the same trophic level competing for shared
resources. The fitted antibiotic susceptibilities εi are mostly negative, indicating that
antibiotics tend to deplete the growth rates microbial populations.
The CDI model produces microbial trajectories that allow for the simulated
application of medical interventions. Previous work explored the effects of antibiotics
on microbial dynamics [2, 4] in this CDI model, and found that the CDI model
exhibits the clinically- and experimentally-observed outcome that antibiotic-treated
microbiomes were vulnerable to CDI.
To demonstrate antibiotic-induced CDI in the gLV model, Fig. 1.2 shows sim-
ulated microbial trajectories that result from applying four separate intervention
scenarios to an initial condition measured by Buffie et al. For clarity, these figures
plot the total microbe count on a log scale (in which the total microbe count is the
sum of all of the microbes in each microbial population), and at each time each mi-
crobial population is linearly colored according to its proportion at that time. First,
in Fig. 1.2a the system is not perturbed and the system evolves to a “healthy” steady
state, in the sense that CD is unable to invade this steady state. In Fig. 1.2b the
system is exposed to a unit dose of antibiotics (i.e., u(t) = 1 for 0 ≤ t ≤ 1, and
u(t) = 0 otherwise) which drives the system to an “antibiotic-depleted” state, in
the sense that CD is able to invade it. Bearing this out, in Fig. 1.2c the system is
exposed to a unit dose of antibiotics and then inoculated with CD on day 10 (i.e.
the transplant v is a unit vector of CD applied at time t∗ = 10), and this system
evolves towards an “CD infected” steady state in which CD is present. Finally, in
Fig. 1.2d the system is exposed to a unit dose of antibiotics, inoculated with CD
on day 1, and then also supplemented with an external foreign transplant (i.e. the
foreign population v is composed of an experimentally-measured initial condition
introduced at a time t∗ = 1); due to the direct intervention, this system now evolves
towards the healthy steady state.
In each panel of Fig. 1.2 the colored mice represent attained steady-state micro-
biome compositions: green represents healthy, yellow represents antibiotic-depleted,
and red represents CD-infected. These three steady states of the CDI model resem-
ble the compositions of the experimentally-observed mouse microbiome composi-
tions, including their susceptibility or resilience to CD exposure [3, 2]. In addition
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Fig. 1.2. External interventions can alter the steady-state outcome of
an initial condition. All panels originate from the same experimentally-measured
initial condition, but different panels correspond to different interventions: (a) no
interventions occur; (b) one dose of antibiotics administered at day 0; (c) one dose
of antibiotic administered at day 0, and CD inoculation on day 10; and (d) one
dose of antibiotic administered at day 0, CD inoculation on day 1, followed by
the immediate introduction of a foreign microbial population made up of a stable
microbial community on day 1. Together these panels demonstrate that antibiotic-
induced CDI may be remedied by the administration of a direct intervention, as in
fecal microbiota transplantation. This figure and caption are adapted from [4].
to these three steady states, two other steady states can be reached by initializ-
ing the system at one of the nine experimentally-measured initial conditions and
then applying some type of intervention. We call this set of five steady states the
“reachable” steady states of the CDI model, and focus on the ecological dynamics
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Fig. 1.3. Microbial composition of reachable steady states. Under the gLV
model Eq. (1.1) and for each of the nine experimentally-measured initial conditions,
every treatment scenario tested in this chapter resulted in one of the steady states
A-E. Together these five steady states encompass a region of phase space that is
relevant for systems originating near the nine measured initial conditions. The green,
red, and yellow mice represent respectively the healthy, CD-infected, and antibiotic-
depleted steady states of the CDI model. Note that while steady states A and D
appear indistinguishable in this plot, their compositions vary slightly. This figure
and caption are adapted from [4].
near them. The microbial compositions of these five steady states are displayed in
Fig. 1.3. In this figure, the previously-mentioned healthy state is labeled steady state
C, the antibiotic-depleted state is labeled steady state E, and the CD-infected state
is labeled steady state D.
This experimentally-characterized CDI model provides a clinically-motivated
case study in which different steady states can be associated with biologically mean-
ingful microbiome compositions. It is pertinent to be able to efficiently switch basins
of attraction in order to attain a “healthy” state, and in the remainder of this chapter
we investigate this goal in detail.
1.2.3 Approximation of bistable gLV dynamics
The ecological dynamics of high-dimensional gLV systems are straightforward to
simulate, but difficult to investigate analytically. Often the most fundamental fea-
tures of a model are captured not by the particular high-dimensional vector that
describes the state of a system, but rather by an abstract biological outcome asso-
ciated with the state of a system. For example, in the case of the CDI model, the
most important question is whether the system will tend towards a healthy (steady
state C) or an antibiotic-depleted state (steady state E), and the precise compo-
sition of those steady states is not as important. Thus, in some sense there is a
low-dimensional description of the transition between a pair of steady states, even
while the actual ecological dynamics flow in a high-dimensional state space.
In earlier work we exploited this abstract outcome-oriented perspective to de-
sign steady-state reduction (SSR) [6]. This method compresses a bistable region of
1 Navigation and control of outcomes in a gLV model of the microbiome 7
ya
ecologicalstate space
y1y2
y3 y4,
etc.
,
xb
xa
yb
SSR approximation:
gLV dynamics:
Fig. 1.4. Schematic of steady-state reduction (SSR). A gLV system of N
species (Eq. (1.1)) exhibits two steady states ya and yb, characterized as diseased
(red) and healthy (green). SSR identifies the two-dimensional (2D) gLV system
defined on the 2D subspace spanned by the two high-dimensional steady states
(Eq. (1.4)) that best approximates the high-dimensional system. Specifically, SSR
prescribes 2D parameters (Eqs. (1.5) and (1.6)) that minimize the deviation be-
tween the N-dimensional gLV dynamics dy/dt and the embedded 2D SSR-reduced
dynamics dx/dt. This figure and caption are adapted from [6].
a high-dimensional gLV model into a reduced two-state gLV model in which the
two basis populations correspond to the bistable states of the original model. As de-
picted in Fig. 1.4, this reduced two-dimensional (2D) gLV model is defined on the 2D
subspace spanned by a pair of steady states of the original model, and the subspace
itself is embedded within the high-dimensional ecological phase space of the original
gLV model. The parameters of the reduced model are weighted combinations of the
parameters of the original model, with weights that are related to the composition
of the two high-dimensional steady states. Within this subspace, these reduced dy-
namics constitute the best possible 2D gLV approximation of the high-dimensional
gLV dynamics. Though gLV systems in general are capable of displaying periodic
or chaotic behaviors, here our attention is restricted to trajectories that approach a
fixed point, and in particular to regions of phase space that are near the border of
the basins of attraction of a pair of steady states (i.e., near the separatrix).
More explicitly, to determine the SSR-reduced 2D gLV system associated with a
bistable high-dimensional gLV model, first define variables xa and xb in the direction
of unit vectors xˆa and xˆb that parallel the two steady states according to xˆa ≡
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ya/‖ya‖2, and xˆb ≡ yb/‖yb‖2, where ‖·‖2 is the 2-norm. The 2D gLV dynamics on
the subspace spanned by xˆa and xˆb are given by
dxa
dt
= xa(µa +Maaxa +Mabxb), and
dxb
dt
= xb(µb +Mbaxa +Mbbxb).
(1.4)
Here, the in-plane dynamics on this subspace in vector form are written dx
dt
=
dxa
dt
xˆa +
dxb
dt
xˆb.
The 2D parameters generated by SSR are chosen to minimize the deviation
between the in-plane and high-dimensional gLV dynamics  = ‖dy
dt
− dx
dt
‖2 for any
point on the subspace spanned by xˆa and xˆb. The values of the SSR parameters that
minimize  are derived in [6]. When the two steady states ya and yb are orthogonal,
the 2D parameters are given by
µγ =
ρ·y◦2γ
‖yγ‖2
2
, and
Mγδ =
(y◦2γ )
TKyδ
‖yγ‖22‖yδ‖2
, (1.5)
where y◦2 ≡ diag(y)y is the element-wise square of y. When ya and yb are not
orthogonal the interspecies interaction terms become slightly more complicated and
are given by
Mab =
∑N
i,j=1Kij(yaiybj+ybiyaj)(yai−ybi
∑N
k=1 yakybk)
1−(∑Ni=1 yaiybi)2 , and
Mba =
∑N
i,j=1Kij(ybiyaj+yaiybj)(ybi−yai
∑N
k=1 ybkyak)
1−(∑Ni=1 ybiyai)2 , (1.6)
where γ, δ ∈ a, b, and yai and ybi are the ith components of the of the unit vectors
yˆa ≡ ya/‖ya‖2 and yˆb ≡ yb/‖yb‖2, respectively. Under this construction, the high-
dimensional steady states ya and yb have in-plane steady state counterparts at
(‖ya‖2, 0) and (0, ‖yb‖2), respectively.
Crucially, this reduced 2D gLV system is analytically tractable: the separa-
trix can be written analytically [6], and bifurcation analyses readily inform how
interaction parameters alter the basins of attraction of a system [7]. SSR associates
complex high-dimensional dynamics with an intuitive low-dimensional system. In
the context of the CDI model, this SSR-based understanding informs the transition
between e.g. the healthy “green” and antibiotic-depleted “yellow” microbial states,
and eschews the high-dimensional details. Later, we will decompose multistable gLV
systems into a web of bistable subsystems, then use this web to describe the geome-
try of the basins of attraction of steady states of the model as an attractor network.
Additionally, SSR will be leveraged to analytically compute the location of the sepa-
ratrix in each subsystem, which is much more efficient than computing the locations
of the separatrices numerically.
1.2.4 Transplant size and timing affect the efficacy of direct
interventions
It is difficult to discern the influence of transplant size and timing on transplant
efficacy in high-dimensional gLV systems, since only numerical methods are available
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Fig. 1.5. The success of direct interventions depends on the size and tim-
ing of the transplant. We consider a clinically-inspired scenario that parallels
antibiotic-induced CDI in the 2D gLV system Eq. (1.4). First, a health-prone ini-
tial condition (IC) is depleted by antibiotics (RX, orange). If a direct transplant
(FMT, brown) is administered shortly after the antibiotics, the treatment steers the
composition to a healthy state (FMT success). Also, if the direct transplant is large
enough to cross the separatrix, the intervention will be successful. Alternatively, if
FMT administration is delayed and the transplant is too small, the microbial tra-
jectory will instead attain the diseased state (FMT failure). The basins of attraction
of the healthy and diseased steady states are delineated by the separatrix, and the
light contours depict isoclines of the potential energy landscape (given by a split
Lyapunov function). This figure and caption are adapted from [6].
to probe this relationship. However, SSR provides a link between high-dimensional
and reduced 2D systems, allowing the mechanisms that underlie direct interventions
in high-dimensional systems to be understood in terms of their low-dimensional
counterparts.
Fig. 1.5 demonstrates how variability in transplant size and timing affects
steady-state outcomes in a clinically-motivated scenario of CDI in a 2D gLV system.
Here, an initial condition is depleted by antibiotics (RX) to the extent that it enters
a diseased basin of attraction. Immediately, the reduced system makes clear that
the location of the separatrix is crucial in determining the outcome of a microbial
state: successful direct interventions must cross the separatrix. The transplant size
required for success depends on the composition of the transplant (in this figure
transplants are composed entirely of x˜b). Furthermore, the required transplant size
is variable, and depends on the ecological dynamics of the system— in Fig. 1.5 a
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transplant of the same size and composition is administered at two different times,
but the later transplant is unsuccessful.
SSR allows for the relationships between transplant size, composition, and tim-
ing to be examined analytically in terms of an intuitive low-dimensional system.
Next, having characterized the operation of direct transplants in a two-dimensional
system, we examine how direct transplants may be used to transition between steady
states in the full context of a multistable gLV system.
1.3 Results
1.3.1 Transplant compositions and their success rates
Having demonstrated that transplants are capable of shifting an ecological state into
a different basin of attraction, we now investigate how transplant composition influ-
ences transplant efficacy. Three intervention types are considered: the introduction
of a single-species “probiotic,” a stable community via “fecal microbiota tranplan-
tation” (FMT), or the elimination of a single species via “phage therapy.” These
interventions act as in silico proxies for medical therapies. The success rates of these
interventions are plotted as a function of the intervention magnitudes in Fig. 1.6.
As an example, the transplant administered in Fig. 1.2d is considered a “successful”
intervention, since it was able to alter a trajectory tending towards steady state
D (the CD-infected steady state) and drive it towards steady state C (the healthy
steady state).
Fecal microbiota transplantation is implemented in the model by setting the
transplant v proportional to a steady state of the gLV system. In particular, trans-
plants v are set proportional to one of the five reachable steady states depicted in
Fig. 1.3, or they are set proportional to one of the nine experimentally-measured ini-
tial conditions from the mouse experiment performed by Buffie et al. [3]. Probiotics
are realized by setting the transplant v proportional to a single microbial species.
Lastly, phage therapies are described by making the transplant v negative, and set-
ting it proportional to a single microbial species (so that it depletes a particular
species).
In Fig. 1.6 these interventions are applied to initial conditions located at the
reachable steady states of the CDI model depicted in Fig. 1.3. Interventions are
considered successful when they shift the basin of attraction an initial condition is
in. For the single species “probiotic,” transplants are solely composed of one of the 11
bacterial species of the model. The steady state “FMT” populations are composed
of one of the five reachable steady states. There are 11 “phage” interventions that
each deplete a single bacterial species. Lastly, the nine “experimental IC” foreign
populations are proportional to the experimental initial conditions measured by
Buffie et al. [3]. In Fig. 1.6 the success rates of each intervention are plotted according
to their magnitude (i.e. the one-norm ‖v‖1 of each foreign population). For scale,
the five reachable steady states of the CDI model vary in size between 3× 1011 and
24× 1011 microbes, which informs the range of direct intervention sizes considered
here.
As shown in Fig. 1.6, the success rates of multi-species interventions (steady
states and experimental ICs) are significantly higher than the single-species inter-
ventions (single-species and phage therapies). In particular, phage therapies are
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Fig. 1.6. Success rates of different microbial interventions at altering
steady-state outcomes. Initial conditions were located one of the five steady states
of the CDI model (displayed in Fig. 1.3) that were reached from experimentally-
measured initial conditions. Then these initial conditions were subjected to the in-
troduction of a foreign population v over a range of sizes ‖v‖1 (as shown on the
x-axis). If the introduced foreign population drove the initial condition into a differ-
ent basin of attraction, the intervention was considered “successful.” For each of the
four types of intervention, several candidate transplants v were implemented, and
the success rates of each candidate intervention were plotted (dashed lines). A bulk
success rate for each type of intervention (bold lines) was produced by averaging
the success rates of the candidate transplants for each intervention type. Details
about the candidate transplant compositions used for each type of intervention are
described in the main text.
completely ineffective at altering the basin of attraction that an initial condition
is in. For each type of intervention, the success rates of each candidate transplant
within each intervention type are plotted in dashed lines. The bulk success rates of
each intervention are plotted in bold, and are computed by averaging the success
rates of the individual introduced foreign populations within each intervention type.
1.3.2 The dynamical landscape of a gLV system
The ecological dynamics of gLV systems are dictated by complex feedbacks between
populations. Conceptually, in the absence of periodic or chaotic dynamics these
ecological dynamics can be interpreted as flowing downhill a dynamical landscape
(e.g. a Lyapunov function) towards a point attractor. A visualization of a dynamical
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(A) Dynamical Landscape (B) Attractor Network
compression
Fig. 1.7. Schematic of a dynamical landscape and its corresponding at-
tractor network. (A) Ecological dynamics that are not periodic or chaotic may
be represented as particles flowing on a dynamical landscape. Here, this artificial
landscape exhibits three stable steady states at A (yellow), B (blue), and C (green).
The basins of attraction are colored according to the color of their associated steady
state, and isoclines of the landscape are also plotted. The black dotted line displays
the value of the energy landscape along convex combinations of steady-state pairs.
(B) To compress this dynamical landscape into an attractor network, a graph is
made in which nodes are steady states and edges are convex combinations of those
steady states. The edge color for a particular convex combination corresponds to the
basin of attraction of that ecological state. The small black circles in the attractor
network correspond to the separatrices of the dynamical landscape. The transplants
v˜1, v˜2, and v˜3, whose compositions are given in the main text, demonstrate how
direct interventions can alter the basin of attraction a system is in.
landscape for a two-dimensional state space is displayed schematically in Fig. 1.7a.
Here, the stable steady states A (yellow), B (blue), and C (green) are located at the
minima of the landscape. Basins of attraction are displayed topographically and are
the same color as their associated steady state.
In the CDI model, as demonstrated in Fig. 1.2 three distinct steady states can
be reached from the same initial condition by administering different interventions
(antibiotic administration and CD exposure). In earlier work we showed that the
transition between these steady states is sudden as a function of the magnitude of
the intervention (for example, an antibiotic dose of 0.70 units leads to steady state C,
while a dose of 0.72 units leads to steady state E) [4]. Thus, the basins of attraction of
these three steady states are touching, but the structure of this high-dimensional dy-
namical landscape is difficult to visualize. To rectify this, attractor networks can be
used to compress information about the basins of attraction of the high-dimensional
phase space into a visually-digestible form. Attractor networks were originally in-
troduced by Wang et al. to study the controllability of gene regulatory networks
associated with cancer [8].
In the schematic Fig. 1.7, panel (B) displays the attractor network for the
dynamical landscape in panel (A). In the attractor network, nodes are steady states
of the high-dimensional system, edges are convex combinations of pairs of steady
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states, and the colors along edges correspond to the basins of attraction along each
convex combination.
Attractor networks are especially valuable for mapping the landscape near a
few steady states in a high-dimensional system. For example, Fig. 1.8 presents an
attractor network for the five reachable steady states of the CDI model (described in
Fig. 1.3). The attractor network preserves geometric information about the basins
of attraction of these five steady states, without requiring awkward visualization of
an 11-dimensional state space.
The realization of antibiotic-induced CDI, as demonstrated in Fig. 1.2, in-
dicated that (i) antibiotic administration shifted a microbial trajectory from the
healthy steady state C towards the antibiotic-depleted steady state E, (ii) antibi-
otic exposure coupled with CD inoculation caused the microbial trajectory to flow
towards the CD-infected steady state D, and (iii) trajectories in the basin of attrac-
tion of the CD-infected steady state D could be driven to the healthy steady state
C through the introduction of a foreign population. The attractor network provides
a compressed description of how an ecological state responds to external interven-
tions, and complements and strengthens the numerical proof-of-concept analysis of
antibiotic-induced CDI in Fig. 1.2.
1.3.3 Efficient navigation of an attractor network
The attractor network acts as a “roadmap” for a dynamical landscape, places mi-
crobial trajectories in the context of other nearby attractors, and can guide the
administration of interventions in a gLV model. In discussing how to navigate gLV
systems, we will assume that we are able to drive the state of the system along
convex combinations of pairs of steady states.
Explicitly, represent steady states A, B, and C in Fig. 1.7 by the vectors xA,
xB , and xC , respectively. Then, starting from steady state i, a direct intervention in
the direction of steady states j corresponds to a transplant v˜ = p(xj−xi) in the gLV
equations Eq. (1.2), where p varies between 0 and 1 and describes the magnitude of
the intervention. For example, in the schematic attractor network Fig. 1.7b, starting
from steady state A an introduced transplant v˜1 = 0.3(xB−xA) will drive the state
of the system into the basin of attraction of steady state B.
Explicitly, we seek to minimize the size of the intervention required to drive a
system from an initial steady state into the basin of attraction of a target steady
state ‖v˜‖. Using the same schematic attractor network from Fig. 1.7b, driving an
initial condition at steady state B into the basin of attraction of steady state C will
require a transplant v˜2 = 0.3(xC−xB). In this schematic the distances between each
pair of steady states is defined to be one unit, so applying these two interventions in
a sequential manner will drive an initial condition at steady state A into the basin
of attraction of steady state C with a total intervention size of 0.6. Alternatively, to
drive an initial condition at steady state A into the basin of attraction of steady state
C directly requires a transplant v˜3 = 0.7(xC −xA), with a total intervention size of
0.7. Thus, constructing an attractor network demonstrates that inherent ecological
dynamics can be leveraged to efficiently control the state of an ecological system.
In the CDI model, the attractor network in Fig. 1.8 reveals that scenarios exist
in which the most efficient control method follows indirect paths. In Fig. 1.9 the
microbial time courses associated with two control protocols— one that follows a
direct path, and another that follows a circuitous path— are compared.
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Fig. 1.8. Attractor network of the five reachable steady states in the CDI
model. The small black circles on each edge represent the numerically-calculated
separatrices of each convex combination of steady states, which denote the bound-
ary of the basins of attraction for a pair of steady states. The relationships be-
tween steady states C (healthy), D (CD-infected), and E (antibiotic-depleted) are
explored numerically in Fig. 1.2. Representing the basins of attraction of these reach-
able steady states as an attractor network allows for an intuitive low-dimensional
description of the dynamical landscape of the high-dimensional CDI system.
Explicitly, let steady state i of the CDI model correspond to the vector yi.
To transition from the antibiotic-depleted steady state E directly to the healthy
steady state C requires a transplant v1 = 0.162(yC − yE), with total transplant
size ‖v3‖ = 2.576, where ‖·‖ is the 2-norm and each transplant is in units of 1011
microbes. A similar control protocol is plotted in Fig. 1.9a, which successfully drives
the state of the system into the basin of attraction of steady state C (the plotted
transplant w1 is chosen to be slightly larger than the required transplant v1 for
demonstrative purposes).
However, in this CDI model it is most efficient to apply two sequential inter-
ventions v2 and v3: the first transplant drives the system towards the CD-infected
steady state D, v2 = 0.001(yD − yE); and the second transplant drives the system
towards the healthy steady state C, v3 = 0.022(yC − yD). Here, since steady state
E is unstable in the direction of steady state D, an infinitesimal transplant is all
that is needed (though for practical purposes we use a value of 0.001). The sizes
of these two sequential transplants are ‖v2‖ = 0.0001 and ‖v3‖ = 0.360. A similar
sequential control protocol is demonstrated in Fig. 1.9b; once again, for demonstra-
tive purposes the transplants w2 and w3 are chosen to be slightly larger than the
required transplants v2 and v3.
Taken together, the circuitous control protocol E → D → C (total transplant
size 0.36) requires a smaller total intervention than the direct path E → C (total
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Fig. 1.9. Direct interventions drive a microbial composition at steady
state E (antibiotic-depleted, yellow mouse) towards steady state C
(healthy, green mouse). (a) The microbial trajectory associated with a con-
trol protocol that drives the system directly from steady state E to steady state
C. This control protocol introduces a transplant w1 = 0.18(yC − yE) on day 10.
The introduced transplant is of size ‖w1‖ = 2.85× 1011 microbes. (b) A circuitous
control protocol drives the system at steady state E first towards steady state D
(CD-infected, red mouse), and then applies a second transplant to drive the system
to steady state D. By administering two smaller transplants sequentially, this con-
trol protocol requires fewer total microbes. requires a smaller fewer total microbes.
The protocol in (b) requires a cumulative transplant size that is 23% the size of the
protocol in (a).
transplant size 2.57). In general, taking advantage of this “ecological inertia” may
reduce the magnitude of the intervention required to drive the system towards a
target state.
16 Eric W. Jones, Parker Shankin-Clarke, and Jean M. Carlson
Fig. 1.10. Attractor network generated exactly (numerically) and approx-
imately (with SSR). This figure is identical to Fig. 1.8, but in addition to the
small black circles corresponding to the numerically-calculated separatrix, the small
black squares correspond to the separatrix locations as predicted by SSR. SSR in-
correctly predicts that any convex combination of steady states B and D will evolve
towards steady state D, when in fact any convex combination of these steady states
will evolve towards steady state A. Despite this inaccuracy, SSR effectively and ef-
ficiently approximates the geometry of the dynamical landscape of the CDI gLV
system.
1.3.4 Efficient construction of attractor networks with steady-state
reduction
Finally, attractor networks can be approximated in constant time (in algorithmic
complexity terms) with the dimensionality-reduction technique SSR. The attractor
network for the CDI model in Fig. 1.8 was generated numerically by simulating
a set of microbial trajectories, each originating at initial conditions along convex
combinations of steady-state pairs, and then tracking the steady-state outcome of
each simulation. This procedure is computationally expensive even when bisection-
type algorithms are implemented to identify the location of the separatrix.
As derived in previous work, SSR allows for the separatrix of the approximate
SSR-reduced 2D gLV system to be computed analytically in a Taylor series about
a semi-stable fixed point (x∗a, x
∗
b) of the reduced system [6]. For example, the sep-
aratrix of the 2D gLV system in Fig. 1.5 was created in this fashion. Though the
current attractor network is relatively small, consisting of five nodes and
(
5
2
)
edges,
scaling up the size of a numerically-calculated attractor network quickly becomes
computationally infeasible. On the other and, larger attractor networks can be effi-
ciently approximated with SSR: as a demonstration of the accuracy with which SSR
captures the location of the separatrices, in Fig. 1.10 the squares on each edge rep-
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resent the separatrix predicted by applying SSR to the corresponding steady-state
pair.
The SSR-generated attractor network incorrectly predicts that convex combi-
nations of steady states B and D will flow towards steady state D, when in fact
they will flow towards steady state A. This occurs because the pairwise connections
in the graph representation of the attractor network may oversimplify the complex
topography of the original landscape. Still, the strong agreement between the exact
and SSR-generated separatrices indicates the potential of SSR to efficiently gener-
ate large attractor networks to first-order that intuitively describe relevant ecological
dynamics.
1.4 Discussion
In this section we provide additional biological, ecological, and mathematical context
for the microbiome control problem considered in this paper. First, Section 1.4.1
discusses biological evidence relating microbiome composition to host health, as
well as clinical evidence for the success of FMT in treating CDI. Then, Section 1.4.2
surveys different classes of ecological models (of varying levels of complexity) that
have been used to model the microbiome. Finally, Section 1.4.3 considers techniques
from nonlinear control theory that might be applicable to gLV systems in future
work.
1.4.1 Microbiome composition is associated with host health
Microbiome research has been the recent beneficiary of advances in experimental
16S pyrosequencing techniques that have revealed similarities in the microbiome
compositions of people suffering various diseases, which differ from the microbiome
compositions of healthy individuals [9]. These disease-associated microbiome com-
positions are called dysbiotic, and are observed in people that suffer cardiovascular
disease, ulcerative colitis, and irritable bowel disease [10, 9].
In this chapter we studied a mathematical model of C. difficile infection (CDI).
CDI occurs when the bacteria C. difficile (CD) colonizes the gut and becomes suf-
ficiently abundant to induce colon inflammation and diarrhea via the production of
toxins TcdA and TcdB [11]. This disease is an explicit example of how impaired
microbiome compositions cause disease.
Traditional treatments for CDI seek to eliminate the presence of CD by admin-
istering antibiotics like vancomycin or metronidazole [12]. However, CDI recurrence
rates that range from 30-65% and concerns about antibiotic resistance have her-
alded fecal microbiota transplantation (FMT) as an alternative treatment for CDI
[13, 14]. FMT is a bacteriotherapy that attempts to alter the composition of a dys-
biotic microbiome (e.g., the microbiome of a person suffering CDI) by engrafting a
foreign microbial population provided by a healthy donor into it. When successful,
FMT causes the restoration of a healthy microbiome, which suppresses the growth
of CD as well as the production of CDI-associated toxins [15]. The success rate of
FMT for treating CDI approaches 90% [13].
FMT has been proposed as a treatment for other gastointestinal diseases includ-
ing irritable bowel syndrome (IBS), inflammatory bowel disease, ulcerative colitis,
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and Crohn’s disease. Recent clinical trials have returned promising but inconclusive
evidence regarding the success of FMT in treating these conditions [16, 17, 18, 19].
For other conditions with distinct microbial signatures— for example, autism spec-
trum disorder (ASD) or metabolic syndrome [20, 21] — a more intrinsic question
regarding the efficacy of bacteriotherapies remains: can symptoms of these conditions
be ameliorated by altering the gut microbiome composition? For ASD, preliminary
evidence supports this hypothesis. Patients with ASD were given Microbiota Trans-
fer Therapy, a treatment that consists of an initial course of antibiotics followed by
regular FMT treatments for ten weeks, and this treatmenet caused lasting shifts to
their microbiome compositions and reductions in their ASD symptoms [22].
At this time, the ability of FMT to treat microbiome-associated diseases is
variable. FMT appears to be an effective treatment for CDI, but recent clinical
studies have been unable to conclusively show that FMT is an effective treatment
for IBS [23]. Part of this discrepancy might be due to antibiotics, which are typically
administered to CDI patients before FMT is attempted. More generally, the factors
that contribute to the success or failure of FMT are not yet fully known. To shed light
on these factors, this chapter used mathematical models to examine the ecological
dynamics that underlie FMT.
1.4.2 Advances in modeling the microbiome
Models of the microbiome can span levels of organization, stochasticity, neutrality,
and complexity. Recent advances in multi-omics sequencing have buoyed micro-
biome modeling by measuring the abundances of the microbial genomes, mRNA
transcripts, proteins, and metabolites contained in the microbiome [24].
For microbial ecosystems with well-characterized metabolic pathways, flux bal-
ance analysis (FBA) predicts the production and consumption of metabolites by
microbes at steady state using inferred stochiometric matrices [24]. In dynamic flux
balance analysis (dFBA), FBA is generalized to track metabolite abundances over
time, at the expense of requiring additional kinetic parameters in the model [24].
In both of these metabolite-based analyses, fine-grained details about metabolite
kinetics need to be either measured or fit. This required level of detail makes FBA
and dFBA ill-suited for analyzing complex microbial ecosystems like the human
microbiome which, for example, consists of ∼1000 microbial species and ∼100000
metabolites [25, 26].
To account for the complexity present in real-world microbial systems, coarse-
graining approaches have been employed to model aggregate microbial dynamcs and
processes. For example, in wastewater treatment activated sludge models (ASMs)
track the abundance of only a few nutrients (e.g. organic carbon, nitrogen, and phos-
phorus) and the population dynamics of only a few aggregate microbial populations
(e.g. microbes that consume carbon, nitrogen, and phosphorus) [27]. Though less
detailed than FBA and dFBA models, ASMs require significantly fewer parameters
and are able to provide relevant information regarding the design and function of
wastewater treatment processes.
Generalized Lotka-Volterra (gLV) models, which are studied in this chapter,
assume that the production and consumption of nutrients can be implicitly cap-
tured by pairwise interactions between microbial populations. Thus, gLV models
only track microbial population abundances. Some gLV models (including the CDI
model) assume that microbial species within a genus are indistinguishable, and study
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microbial dynamics coarse-grained at the genus level. Part of the convenience of gLV
models is that they may be parameterized with time-series microbial abundance
data, which is readily available due to advances in genomic sequencing. Several al-
gorithms have been developed to infer growth rate and interaction parameters of
gLV models from time-series abundance data (e.g. LIMITS [28, 29]). gLV models
have been used to investigate microbial interactions in cheese [30], to probe how
antibiotic perturbations alter the gut microbiome in the context of CDI [2], and to
inform treatment of polymicrobial urinary tract infections [31]. When gLV models
accurately approximate the underlying microbial systems, simulated interventions
(e.g. antibiotic administration or fecal microbiota transplantation) can guide clinical
efforts to alter the composition of diseased microbiomes [2, 32, 4].
Each of these previously discussed models make the simplifying assumption
that microbial processes and the resulting microbial dynamics are deterministic. In
ecology these deterministic approaches are typically used to model niche processes.
While microbial dynamics can be relatively consistent in some systems (e.g. in soil
microbial communities [33]), variability— reflecting neutral processes— is gener-
ally evident in microbial communities (e.g. in human [34] or fly [35] microbiomes).
Mathematical models have been developed to account for this variability [36]. For
example, Sloan et al. proposed a model to predict microbial abundances based solely
on birth-death processes and immigration following Hubbell’s neutral theory [37],
while the Ricker model has been used to introduce stochasticity into gLV models
[28].
1.4.3 Alternate approaches from nonlinear control theory
Existing theory describes the controllability of polynomial differential equations us-
ing differential geometry [38], and these techniques should be applicable to gLV
systems. For example, the Pontryagin maximum principle provides a necessary con-
dition for whether a proposed control protocol is optimal [39]. This approach has
been previously applied to a optimal sampled-data control problem in the context of
a biomechanical model that predicts how muscles respond to electrical stimulations
[5]. In this biomechanical study, a version of the Pontryagin maximum principle
specific to optimal sampled-data control problems was used to identify the optimal
timing of electrical stimulations that maximize the muscular force response [40].
Since our microbiome control problem also treats direct interventions as Dirac delta
inputs, this modified version of the Pontryagin maximum principle could be applied
to gLV systems.
1.5 Conclusion
The ability to control steady-state outcomes of ecological systems has a broad prac-
tical appeal. These control protocols will rely on a foundation of ecological theory
that is still under exploration. Here we introduce a technique to map the dynamical
landscape of gLV systems with attractor networks. Although our analysis was solely
concerned with gLV systems, fundamental ecological behaviors are demonstrated.
For example, when attempting to control the steady-state outcome of a gLV system,
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the relevant objective is driving the system into the target basin of attraction rather
than exactly driving the system to the target steady state. Additionally, when at-
tempting to drive an ecosystem towards a target state, it might be more efficient to
use a multi-step control protocol. With the steady progression of ecological theory
it is feasible that precision bacteriotherapies, based upon ecological models of the
microbiome, will one day become a commonplace medicine for the microbiome.
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Appendix A: Parameters of the 11D CDI gLV model
Barnesiella 0.3680
undefined genus of Lachnospiraceae 0.3102
unclassified Lachnospiraceae 0.3561
Other 0.5400
Blautia 0.7089
undefined genus of unclassified Mollicutes 0.4706
Akkermansia 0.2297
Coprobacillus 0.8300
undefined genus of Enterobacteriaceae 0.3236
Enterococcus 0.2907
Clostridium difficile 0.3918
Table 1.1. Growth rates ρi of each microbial population i of the CDI model con-
structed by Stein et al. [2]. This table and caption are adapted from [4].
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Barnesiella -0.205 0.098 0.167 -0.164 -0.143 0.019 -0.515 -0.391 -0.268 0.008 0.346
und. Lachno. 0.062 -0.104 -0.043 -0.154 -0.187 0.027 -0.459 -0.413 -0.196 0.022 0.301
uncl. Lachno. 0.143 -0.192 -0.101 -0.139 -0.165 0.013 -0.504 -0.772 -0.206 -0.006 0.292
Other 0.224 0.138 0.000 -0.831 -0.223 0.220 -0.205 -1.009 -0.400 -0.039 0.666
Blautia -0.180 -0.051 -0.000 -0.054 -0.708 0.016 -0.507 0.553 0.106 0.224 0.157
und. Mollicutes -0.111 -0.037 -0.042 0.041 0.261 -0.422 -0.185 -0.432 -0.264 -0.061 0.164
Akkermansia -0.126 -0.185 -0.122 0.380 0.400 -0.160 -1.212 1.389 -0.096 0.191 -0.379
Coprobacillus -0.071 0.000 0.080 -0.454 -0.503 0.169 -0.562 -4.350 -0.207 -0.223 0.443
und. Enterobac. -0.374 0.278 0.248 -0.168 0.084 0.033 -0.232 -0.395 -0.384 -0.038 0.314
Enterococcus -0.042 -0.013 0.024 -0.117 -0.328 0.020 0.054 -2.096 0.023 -0.192 0.111
C. difficile -0.037 -0.033 -0.049 -0.090 -0.102 0.032 -0.181 -0.303 -0.007 0.014 -0.055
Table 1.2. Interactions Kij between microbial populations i and j of the CDI model
constructed by Stein et al. [2]. Each interaction Kij describes the effect of population
j on population i. Population i is given on the left, and population j is given on the
top. This table and caption are adapted from [4].
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